Back
Product details:
ID
CAS
936563-96-1
Purity
95%
Ibrutinib is an antineoplastic agent used to treat chronic lymphocytic leukemia, mantle cell lymphoma, and Waldenstrom's Macroglobulinemia.
Properties
Name
Ibrutinib
Smiles
NC=1N=CN=C2N(N=C(C=3C=CC(OC=4C=CC=CC4)=CC3)C12)[C@@H]5CCCN(C5)C(=O)C=C
Targets
Please log in to see this information
Target name
Target pX
Target action
doi
SDS
IBR | PCI-32765 | ibrutinib | imbruvica
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$19
2 mg
$19
5 mg
$19
10 mg
$19
15 mg
$19
20 mg
$19
25 mg
$19
30 mg
$19
35 mg
$19
40 mg
$19
45 mg
$19
50 mg
$19
75 mg
$19
100 mg
$POA
Quantity
1
Total amount
$ 19
IBR | PCI-32765 | ibrutinib | imbruvica
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.